Live antipsychotics updates

Live antipsychotics news coverage of developments with the latest updates. Stay on top of latest antipsychotics news stories and find out what just happened, what is going on with antipsychotics. The latest real-time news updates and headlines on antipsychotics
Researchers Find Two FDA-Approved Drugs that Curb Symptoms of Alzheimer’s Disease
Scientists find two FDA-approved drugs that curb symptoms of Alzheimer’s
Pfizer Reports Additional Data on PAXLOVID Supporting Upcoming New Drug Application Submission to U.S. FDA
When reality fails: What to know about psychosis
Researchers develop medication-free approach for behavioral changes in Alzheimer’s
Pfizer to Invest $120 Million to Produce Covid Oral Treatment in U.S
Good news, bad news on risky medication use in nursing homes
Hospices vary widely in prescribing “comfort kit” medications
Hospices vary widely in prescribing of “comfort kit” medications
Pfizer Shares Top-Line Results from Phase 2/3 EPIC-PEP Study of PAXLOVID for Post-Exposure Prophylactic Use
Study links Mental illness to increased death from cardiovascular disease
Why Are We So Ashamed of Mental Illness? This Psychiatrist Is Determined to End Stigma
PSA welcomes Government’s commitment to improve medicine safety in Aged Care
Widely used nausea drugs linked to heightened risk of stroke
Pfizer to Supply UNICEF up to 4 Million Treatment Courses of Novel Covid Oral Treatment for Low- and Middle-Income Countries
Statement on Inappropriate Use of Psychotropic Medicines to Manage Behaviours of People with Disability and Older People
Pharmacists can help resolve troubling aged care findings
HRW Submission to UN Committee on Rights of Persons with Disabilities in Ghana
Prescribing of psychiatric drugs to Australian kids on rise
AMA successfully lobbies against amendments to antipsychotics in aged care
Sleep deprivation increases serotonin 2a receptor response in brain
Nearly one in five patients with heart disease use mental health drugs
Prepare to beat heat
Aged care pharmacists needed to improve quality of life for aged care residents
Potential new approach for treatment of schizophrenia
Brain imaging techniques top poll of key milestones in century of neurology
Study finds excess use of non-emergency restraint among older psychiatric patients
Research reveals excess use of non-emergency restraint among older psychiatric patients
Sleep in children with autism
Robotic pet boosts mood, behavior and cognition in adults with dementia
Common antidepressant should no longer be used to treat people with dementia, study says
Schizophrenia diagnosis rises among Black nursing home residents following start of Medicare initiative
Targeting new drugs for schizophrenia
New legal push to stem chemical restraint of aged care residents
Characterized drugs show unexpected effects
Evidence of sustained benefits of pimavanserin for dementia-related psychosis
People entering aged care with new GP experience an increase in medication
Psychiatric patients at increased risk of COVID-19 hospitalization and mortality
Medicine safety experts lay out path to reducing harm caused by medicines in Australia
AMP recommends minimum set of pharmacogenetic alleles to guide clinical CYP2D6 genotype testing, pro
PSA welcomes Government’s commitment to aged care, but more must be done
WA PSA recognises outstanding pharmacists
Researchers find some medicines could raise blood pressure
Medicine Safety is a game of Russian roulette for older Australians
UBC researchers identify most dangerous prescriptions for B.C. drivers
RACGP: Opportunities to improve patient access to GP care missed
Antipsychotics for Treating Adult Depression Linked with Higher Mortality
Identifying risk of unplanned emergency department transfer in aged care